20 June 2013
Keywords: Cipla, DNDI, Pediatric antiretrovirals, IV, AIDS
Article | 24 July 2012
Coinciding with the XIX International AIDS Conference in Washington DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit R& ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 July 2012
19 June 2013
© 2013 thepharmaletter.com